BBN.SW stock dropped 5.32% to CHF 8.90 at market close on 17 Mar 2026 on the SIX exchange, pressured by a higher PE and weak near-term momentum. Volume rose to 54,287 shares, more than double the average, signalling heavier selling. Investors are parsing recent earnings (EPS 0.14) and a stretched PE of 63.57 versus sector norms. We review the drivers, technicals, valuation and short-term forecasts to explain why Bellevue Group AG (BBN.SW) sits among today’s top losers
BBN.SW stock: price action and intraday drivers
Bellevue Group AG (BBN.SW) closed at CHF 8.90, down CHF 0.50 from yesterday and trading within a day range CHF 8.86–9.36. The stock’s relative volume of 2.57x and trade count pushed it onto the top losers list on SIX. One clear driver is weak sentiment after recent earnings: EPS 0.14 and a trailing PE of 63.57, well above the Financial Services sector average PE of 34.43, increasing sensitivity to any negative news.
BBN.SW stock fundamentals: income, cash and valuation
Bellevue reports book value per share CHF 8.78 and cash per share CHF 4.90, giving tangible backing to the current price. Key metrics show a price-to-book of 1.01, price-to-sales 2.25, and free cash flow yield 15.86%. These figures suggest the market values Bellevue closer to net asset levels than growth multiples. One claim: the high PE stems from low net income per share (0.14) rather than a pricing premium on assets.
BBN.SW stock technicals and trading signals
Technicals show short-term weakness: RSI 38.90 and MACD -0.46 with a small histogram rebound. The 50-day average is CHF 10.68 and the 200-day average is CHF 8.88, which places the stock at the lower end of its medium-term band. Volume spikes and an ADX of 30.34 indicate a strong trend. Traders should note Bollinger band lower at CHF 7.44, which aligns with the 52-week low of CHF 7.00 as a possible support area.
BBN.SW stock: sector comparison and risk context
Bellevue operates in Switzerland’s Financial Services sector (Asset Management). The sector’s average ROE is 8.3%, while Bellevue’s ROE is 1.64%, highlighting underperformance. Sector P/B averages near 1.98–4.72 depending on subsector, making Bellevue’s P/B 1.01 relatively modest. Primary risks include slower fee growth (revenue down 13.93% FY 2024) and concentrated niche strategies in healthcare equities that amplify performance swings.
BBN.SW stock: catalysts, dividends and analyst posture
Catalysts include new fund flows, asset performance in specialist healthcare strategies, and any management guidance updates. Bellevue pays dividend per share CHF 0.70, a yield near 7.87% on today’s price, but dividend growth has fallen recently. External sentiment shows a mixed profile: our company rating snapshot lists a B- with a Sell recommendation on certain valuation metrics. Absent positive fund inflows, near-term pressure could persist.
BBN.SW stock outlook and price targets
Meyka AI’s forecast model projects CHF 9.26 in three months, implying a +4.04% upside from CHF 8.90, and a one-year model projection of CHF 4.72, implying -46.97%. Short-term technical resistance sits near CHF 10.68 (50-day MA); practical price targets from an analyst lens: a near-term target CHF 9.50 if flows recover, and a downside risk to CHF 7.00 if fund outflows accelerate. Forecasts are model-based projections and not guarantees.
Final Thoughts
BBN.SW stock closed as a top loser on 17 Mar 2026, trading at CHF 8.90 on the SIX in Switzerland after a day of elevated volume. Fundamentals show solid cash per share (CHF 4.90) and a near 1.0 P/B, but earnings are thin (EPS 0.14) and the trailing PE 63.57 flags valuation risk versus Financial Services peers. Technically, RSI 38.90 and strong volume favour the downside into CHF 7.00 support if net asset growth weakens. Meyka AI’s forecast model offers a near-term projection of CHF 9.26 (+4.04%) and a one-year projection of CHF 4.72 (-46.97%) versus the current price. Our proprietary grade places Bellevue in the middle of the pack while signalling caution for risk-focused investors. For traders, watch flows and the 50-day MA CHF 10.68 as a recovery trigger. For longer-term income investors, the CHF 0.70 dividend and strong cash position are positives, but they must weigh dividend sustainability against falling revenue trends. This analysis is provided by Meyka AI, an AI-powered market analysis platform, and is informational, not investment advice.
FAQs
What caused BBN.SW stock to fall today?
BBN.SW stock fell due to elevated selling on higher volume, a high trailing PE of 63.57, and weaker earnings momentum (EPS 0.14). Market sentiment and fund flow concerns in asset managers amplified the drop.
Is BBN.SW stock cheap based on valuation?
On price-to-book, BBN.SW stock trades at 1.01, near book value CHF 8.78. However, high PE and falling revenue growth make the valuation mixed rather than an outright bargain.
What is the short-term forecast for BBN.SW stock?
Meyka AI’s forecast model projects CHF 9.26 in three months, implying +4.04% upside from CHF 8.90. Forecasts are model-based and not guarantees.
Does Bellevue (BBN.SW) pay a dividend?
Yes. Bellevue reports a dividend per share of CHF 0.70, which equals about 7.87% yield on today’s price. Dividend sustainability depends on earnings and fund flows.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)